Lv1
18 积分 2022-03-24 加入
B-cell non-Hodgkin lymphomas
8小时前
待确认
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma
10小时前
已完结
重视慢性移植物抗宿主病的临床管理
7个月前
已完结
[Expert consensus on day care cancer diagnosis and treatment in China (2022 Edition)]
1年前
已完结
Potential future direction of measurable residual disease evaluation in multiple myeloma
1年前
已完结
Diagnosis for Chinese patients with light chain amyloidosis: a scoping review
1年前
已完结
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
1年前
已完结
Comparación indirecta ajustada de zanubrutinib e ibrutinib en el tratamiento de primera línea de la leucemia linfocítica crónica
1年前
已完结
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies
1年前
已完结
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
1年前
已完结
皖公网安备34019202002308
